Trials / Completed
CompletedNCT02481947
A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 459 (actual)
- Sponsor
- Braintree Laboratories · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate a daily dose of BLI400 Laxative for safety and efficacy versus lubiprostone in constipated adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BLI400 Laxative | 21 gm BLI400 powder |
| DRUG | Lubiprostone | 24 mcg capsule bid |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2015-11-01
- Completion
- 2015-11-01
- First posted
- 2015-06-25
- Last updated
- 2020-07-27
- Results posted
- 2020-06-25
Locations
50 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02481947. Inclusion in this directory is not an endorsement.